InterventionsReview

Efficacy and diabetes risk of moderate-intensity statin plus ezetimibe versus high-intensity statin after percutaneous coronary intervention: A systematic review and meta-analysis

Journal of Clinical Lipidology

The paper

Kelly FA, Moreira Rêgo LHR, Rebelo TG et al.

Journal of Clinical Lipidology · 4 Aug 2026

doi.org/10.1016/j.jacl.2026.07.036 PubMed 42716850

Most US adults meeting PREVENT risk thresholds lack lipid therapy
American Journal of Preventive Cardiology · 4 Oct 2026
Early statin use links to lower dementia risk in diabetes
The Lancet Regional Health Europe · 4 Oct 2026
Four health profiles linked to heart disease and diabetes risks
Diabetes, Obesity & Metabolism · 6 Oct 2026
Orforglipron matches insulin glargine on cardiovascular safety
Lancet · 4 Oct 2026